Identification, Biopsy, and Treatment of Poorly Understood Premalignant, in Situ, and Indolent Low-Grade Cancers: Are We Becoming Victims of Our Own S

Identification, Biopsy, and Treatment of Poorly Understood Premalignant, in Situ, and Indolent Low-Grade Cancers: Are We Becoming Victims of Our Own Success?
Ferris M. Hall
Radiology 2010;254 655-659
Link to Journal

Imagers are increasingly detecting and performing percutaneous biopsies on borderline, preinvasive, or low-grade cancers that were heretofore rarely identified and that may never progress to meaningful disease.